Posttransplant Complications

1

Review clinical trials related to Posttransplant Complications. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

The transplantation of allogeneic haematopoietic stem cells (HSCs) can lead to serious complications after transplantation, such as graft-versus-host disease (GvHD), infections and relapse due to immunosuppression. Invariant NKT cells (iNKT cells) play a pivotal role in modulating the immune response and have been demonstrated to be instrumental in the pathogenesis of GvHD, cytomegalovirus (CMV) infection, and relapse. Their levels are associated with the development of these complications. This multicentre study aims to test the feasibility of standardising iNKT cell monitoring and to investigate the association between iNKT cell levels and post-transplant complications.

Participants needed: 75
Trial details
Age: 18-70Biological sex: AllType: ObservationalSponsor: University Hospital PilsenUpdated: May 6, 2026Locations: 1
Eligibility criteria

Diagnosis: AML (exlusion of secondary disease) [+3]

Prior transplant [+1]